US Stock MarketDetailed Quotes
PHH Park Ha Biological Technology
- 0.000
- 0.0000.00%
Close Nov 29 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)26.20MShares0.00052wk High0.00P/B0Float Cap0.00052wk Low--Dividend TTM1.20MShs Float0.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
Park Ha Biological Technology Key Stats
Quarterly+Annual
YOY
| (FY)Oct 31, 2023 | (FY)Oct 31, 2022 | (FY)Oct 31, 2021 | (Q2)Jun 30, 2018 | (Q1)Mar 31, 2018 | (FY)Dec 31, 2017 | (Q4)Dec 31, 2017 | (Q3)Sep 30, 2017 | (Q2)Jun 30, 2017 | (Q1)Mar 31, 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -91.23%126.54K | 389.70%1.44M | -497.86K | 61.27%-55M | -15.10%163M | 309.46%303M | 466.67%306M | -133.97%-53M | 9.55%-142M | 814.29%192M |
| Net income from continuing operations | 345.40%852.04K | 139.45%191.3K | ---484.96K | 30.00%-35M | 57.75%-30M | -0.52%-194M | 76.69%-31M | -100.00%-42M | -455.56%-50M | -136.67%-71M |
| Operating gains losses | ---- | ---- | ---- | 117.53%17M | -25.00%-30M | 1.50%-262M | -82.98%-86M | 35.29%-55M | 17.09%-97M | -41.18%-24M |
| Depreciation and amortization | -34.20%20.06K | -21.83%30.49K | --39.01K | -33.33%2M | -25.00%3M | -12.50%14M | 0.00%3M | 0.00%4M | -40.00%3M | 0.00%4M |
| Deferred tax | -2,519.33%-33.74K | ---1.29K | --0 | ---- | --0 | -10.99%-101M | 600.00%80M | -435.29%-91M | -190.00%-58M | 15.79%-32M |
| Other non cash items | 39.49%45.9K | 1,878.47%32.9K | --1.66K | 44.44%-20M | -4.56%251M | 43.41%707M | 63.39%366M | -57.30%114M | 35.71%-36M | 353.45%263M |
| Change In working capital | -177.62%-911.07K | 2,291.12%1.17M | ---53.57K | -119.79%-19M | -159.62%-31M | 76.62%136M | -93.33%-29M | 112.50%17M | 140.00%96M | 18.18%52M |
| -Change in receivables | -319.54%-603.5K | -208.19%-143.85K | ---46.68K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Change in inventory | -101.46%-2.82K | 1,106.56%193.58K | ---19.23K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Change in prepaid assets | 244.73%8.96K | -49.19%-6.19K | ---4.15K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | 204.07%542.02K | 21.65%178.26K | --146.53K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Change in other current assets | 194.95%178.02K | -2,075.32%-187.49K | ---8.62K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Change in other current liabilities | -35.18%-44.65K | -886.32%-33.03K | ---3.35K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Change in other working capital | -184.36%-989.08K | 1,093.00%1.17M | ---118.08K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -91.23%126.54K | 389.70%1.44M | ---497.86K | 61.27%-55M | -15.10%163M | 309.46%303M | 466.67%306M | -133.97%-53M | 9.55%-142M | 814.29%192M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 166.13%1.02M | -11,890.47%-1.55M | -12.91K | -93.75%2M | -80.00%5M | 294.00%197M | 185.07%57M | 477.27%83M | -50.77%32M | -66.22%25M |
| Net PPE purchase and sale | -90.71%-22.68K | 7.88%-11.89K | ---12.91K | ---1M | ---1M | 94.12%-1M | --0 | ---- | ---- | --0 |
| Net intangibles purchase and sale | ---- | ---- | ---- | -85.00%3M | -91.55%6M | 958.33%127M | 0.00%5M | 933.33%31M | 900.00%20M | 3,450.00%71M |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --1M | ---46M |
| Net other investing changes | 168.12%1.05M | ---1.54M | ---- | ---- | ---- | -98.18%1M | 114.71%10M | 4.76%-20M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 166.13%1.02M | -11,890.47%-1.55M | ---12.91K | -93.75%2M | -80.00%5M | 294.00%197M | 185.07%57M | 477.27%83M | -50.77%32M | -66.22%25M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -201.09%-676.93K | 34.30%669.65K | 498.63K | -93.55%12M | -19.44%-215M | -596.77%-864M | -309.09%-315M | -288.11%-555M | 16.25%186M | -181.25%-180M |
| Net issuance payments of debt | -627.80%-715.19K | -42.48%135.5K | --235.56K | -90.00%11M | -12.78%-203M | -920.45%-898M | -304.29%-283M | -289.29%-545M | -31.68%110M | -361.54%-180M |
| Net common stock issuance | -92.84%38.27K | 103.05%534.15K | --263.07K | ---- | ---- | -1,208.70%-301M | --0 | ---277M | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | --1M | ---12M | 2,676.92%335M | -357.14%-32M | 9,000.00%267M | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -201.09%-676.93K | 34.30%669.65K | --498.63K | -93.55%12M | -19.44%-215M | -596.77%-864M | -309.09%-315M | -288.11%-555M | 16.25%186M | -181.25%-180M |
| Net cash flow | ||||||||||
| Beginning cash position | 690.68%574.71K | -10.41%72.69K | --81.13K | -46.40%536M | -39.46%583M | 0.00%906M | -50.40%494M | 7.06%1.08B | 6.72%1B | 6.29%963M |
| Current changes in cash | -16.18%473.03K | 4,749.43%564.35K | ---12.14K | -153.95%-41M | -227.03%-47M | ---364M | 153.33%48M | -5,733.33%-525M | 11.76%76M | 19.35%37M |
| Effect of exchange rate changes | 77.36%-14.11K | -1,786.23%-62.32K | --3.7K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| End cash Position | 79.85%1.03M | 690.68%574.71K | --72.69K | -54.00%495M | -46.40%536M | -40.18%542M | -40.18%542M | -50.40%494M | 7.06%1.08B | 6.72%1B |
| Free cash flow | -92.74%103.86K | 380.05%1.43M | ---510.77K | 60.56%-56M | -15.63%162M | 429.82%302M | 512.00%306M | -135.53%-54M | 10.69%-142M | 1,271.43%192M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data